In the BioHarmony Drug Report Database
Fluvoxamine
Luvox (fluvoxamine) is a small molecule pharmaceutical. Fluvoxamine was first approved as Luvox on 1994-12-05. It is used to treat depressive disorder, obsessive-compulsive disorder, and panic disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter. In addition, it is known to target sigma non-opioid intracellular receptor 1.
Trade Name
|
Luvox |
|---|---|
Common Name
|
fluvoxamine |
ChEMBL ID
|
CHEMBL814 |
Indication
|
depressive disorder, obsessive-compulsive disorder, panic disorder |
Drug Class
|
Selective serotonin reuptake inhibitor (SSRI) |
Image (chem structure or protein)